Issam Awad to Thrombolytic Therapy
This is a "connection" page, showing publications Issam Awad has written about Thrombolytic Therapy.
Connection Strength
3.784
-
In Reply: Intracerebral Hemorrhage Volume Reduction and Timing of Intervention Versus Functional Benefit and Survival in the MISTIE III and STICH Trials. Neurosurgery. 2021 09 15; 89(4):E247-E248.
Score: 0.690
-
Post-Trial Enhanced Deployment and Technical Performance with the MISTIE Procedure per Lessons Learned. J Stroke Cerebrovasc Dis. 2021 Sep; 30(9):105996.
Score: 0.683
-
Symptomatic Hemorrhagic Complications in Clot Lysis: Evaluation of Accelerated Resolution of Intraventricular Hemorrhage Phase III Clinical Trial (CLEAR III): A Posthoc Root-Cause Analysis. Neurosurgery. 2018 12 01; 83(6):1260-1268.
Score: 0.568
-
Spontaneous intracerebral and intraventricular hemorrhage: advances in minimally invasive surgery and thrombolytic evacuation, and lessons learned in recent trials. Neurosurgery. 2014 Feb; 74 Suppl 1:S142-50.
Score: 0.407
-
Thrombolytic evacuation of intracerebral and intraventricular hemorrhage. Curr Cardiol Rep. 2012 Dec; 14(6):754-60.
Score: 0.375
-
Intracerebral Hemorrhage Volume Reduction and Timing of Intervention Versus Functional Benefit and Survival in the MISTIE III and STICH Trials. Neurosurgery. 2021 04 15; 88(5):961-970.
Score: 0.168
-
Stereotactic computed tomographic-guided aspiration and thrombolysis of intracerebral hematoma : protocol and preliminary experience. Stroke. 2000 Apr; 31(4):834-40.
Score: 0.156
-
Surgery for intracerebral haemorrhage - Authors' reply. Lancet. 2019 08 24; 394(10199):e22-e23.
Score: 0.149
-
Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial. Lancet. 2019 Mar 09; 393(10175):1021-1032.
Score: 0.144
-
Drainage efficiency with dual versus single catheters in severe intraventricular hemorrhage. Neurocrit Care. 2012 Jun; 16(3):399-405.
Score: 0.091
-
Resolution of intraventricular hemorrhage varies by ventricular region and dose of intraventricular thrombolytic: the Clot Lysis: Evaluating Accelerated Resolution of IVH (CLEAR IVH) program. Stroke. 2012 Jun; 43(6):1666-8.
Score: 0.090
-
Low-dose recombinant tissue-type plasminogen activator enhances clot resolution in brain hemorrhage: the intraventricular hemorrhage thrombolysis trial. Stroke. 2011 Nov; 42(11):3009-16.
Score: 0.086
-
Minimally Invasive Surgery With Thrombolysis for Intracerebral Hemorrhage Evacuation: Bayesian Reanalysis of a Randomized Controlled Trial. Neurology. 2023 10 17; 101(16):e1614-e1622.
Score: 0.049
-
Thrombolysis for Evacuation of Intracerebral and Intraventricular Hemorrhage: A Guide to Surgical Protocols With Practical Lessons Learned From the MISTIE and CLEAR Trials. Oper Neurosurg (Hagerstown). 2020 12 15; 20(1):98-108.
Score: 0.041
-
Protocols and critical pathways for stroke care. Clin Neurosurg. 1999; 45:86-100.
Score: 0.036
-
Bleeding and infection with external ventricular drainage: a systematic review in comparison with adjudicated adverse events in the ongoing Clot Lysis Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III (CLEAR-III IHV) trial. Neurosurgery. 2015 Mar; 76(3):291-300; discussion 301.
Score: 0.027
-
A multicenter, randomized, double-blinded, placebo-controlled phase III study of Clot Lysis Evaluation of Accelerated Resolution of Intraventricular Hemorrhage (CLEAR III). Int J Stroke. 2014 Jun; 9(4):536-42.
Score: 0.025